NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-251-2009-0-FR-07 Azicon Beam Polarization Devices FR EP 11706440.2 Issued
NHLBI E-251-2009-0-DE-06 Azicon Beam Polarization Devices DE EP 11706440.2 Issued
NHLBI E-251-2009-0-EP-03 Azicon Beam Polarization Devices EP National Stage 11706440.2 Issued
NIDDK E-102-2011-0-EP-09 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES EP National Stage 11713395.9 Issued
NIDDK E-102-2011-0-FR-11 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES FR EP 11713395.9 Issued
NIDDK E-102-2011-0-DE-10 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES DE EP 11713395.9 Issued
NIDDK E-102-2011-0-GB-12 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES GB EP 11713395.9 Issued
NIDDK E-102-2011-0-CN-07 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES CN National Stage 201180018923.4 Issued
NIDDK E-102-2011-0-AU-05 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES AU National Stage 2011217815 Issued
NIDDK E-102-2011-0-US-03 (N)-Methanocarba Phosphonate Analogues Of 5'-AMP As Cardioprotective Agents US ORD 13/031,805 8822434 Issued PDF
NHLBI E-251-2009-0-PCT-02 Azicon Beam Polarization Devices PCT PCT PCT/US2011/025755 Expired
NIDDK E-102-2011-0-PCT-02 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES PCT PCT PCT/US2011/025680 Expired
NINR E-023-2010-0-PCT-02 Biomarkers for Acute Ischemic Stroke PCT PCT PCT/US11/025748 Expired
NCI E-200-1998-0-JP-33 Fitness Assay and Associated Methods JP DIV 35193/2011 Expired
NIAAA E-060-2010-0-US-06 Hydroxybutyrate Ester And Medical Use Thereof US National Stage 13/031,006 8642654 Issued PDF
NCI E-014-2000-0-US-04 Secreted Frizzled Related Protein, SFRP, Fragments, and Methods Of Use Thereof US DIV 13/031,060 8158603 Expired PDF
NIAID E-250-2005-0-US-44 Methods For Treating And Preventing Fibrosis US DIV 13/030,840 Abandoned
NCI E-234-2010-1-US-01 Biomarkers For Prostate Cancer And Methods For Their Detection. US 61/443,955 Abandoned
NIAID E-076-2011-0-US-01 Compositions and Methods for treating Poliovirus US 61/443,915 Abandoned
NCI E-287-2009-3-US-03 Derivatives of APF And Methods Of Use US National Stage 13/059,292 8912146 Issued PDF
NCI E-290-2007-1-PCT-02 METHOD OF TREATING DISEASE INVOLVING MYELIN AND/OR AXONAL LOSS PCT PCT PCT/US2011/024966 Expired
NCI E-290-2007-1-CA-03 METHOD OF TREATING DISEASE INVOLVING MYELIN AND/OR AXONAL LOSS CA National Stage 2789872 Abandoned
NIAID E-213-2010-1-US-01 HIV Immunogens US 61/443,550 Abandoned
NCI E-263-2004-0-US-04 POT1 Alternative Splicing Variants US DIV 13/027,854 8426379 Abandoned PDF
CC E-029-2011-1-EP-01 Therapeutic apparatus for heating a subject EP ORD 11154471.4 Pending
CC E-029-2011-2-EP-06 Therapeutic Apparatus And Method For Heating A Subject EP DIV 20110154471 Abandoned
NCATS E-069-2014-0-US-01 Novel inhibitors of protein kinase signaling that are neuroprotective and have potential applicability for the treatment of glaucoma, optic nerve disease, and other forms of neurodegeneration US 61/443,035 Abandoned
NIAID E-260-2010-0-US-01 Immunotoxins Against Glycoprotein H Of Kaposi's Sarcoma-associated Herpesvirus US 61/442,902 Abandoned
NINR E-280-2010-0-US-01 Biomarkers For Cancer-Related Fatigue And Use Thereof US 61/442,605 Abandoned
NCI E-159-2010-0-US-06 Multimeric Proteins From Isolated Engineered Antibody Domains US National Stage 13/578,538 Abandoned
NCI E-159-2010-0-EP-05 Multimeric Proteins From Isolated Engineered Antibody Domains EP National Stage 11742876.3 Abandoned
NCI E-159-2010-0-PCT-02 Multimeric Proteins From Isolated Engineered Antibody Domains PCT PCT PCT/US11/024552 Expired
NCI E-159-2010-0-CA-04 Multimeric Proteins From Isolated Engineered Antibody Domains CA National Stage 2789328 Abandoned
NIEHS E-180-2011-3-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US 61/441,912 Abandoned
NCI E-159-2010-0-AU-03 Multimeric Proteins From Isolated Engineered Antibody Domains AU National Stage 2011215684 Abandoned
NCI E-104-2006-0-US-18 Immunogenic Peptides And Methods Of Use US CON 13/025,094 9175057 Issued PDF
NCI E-124-2004-2-US-07 METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR US DIV 13/024,845 Abandoned
NCI E-082-2010-0-PCT-02 Inhibition Of Antibody Responses To Foreign Proteins PCT PCT PCT/US2011/024382 Expired
NHLBI E-011-2010-0-EP-03 Compositions And Methods For Preventing or Treating A Human Parvovirus Infection EP National Stage 11730103.6 Abandoned
NHLBI E-011-2010-0-PCT-02 Compositions And Methods For Preventing or Treating A Human Parvovirus Infection PCT PCT PCT/US2011/024199 Expired
NHLBI E-254-2011-1-US-01 Critical Cysteine Oxidation Is Reduced During Ischemia-Reperfusion
Injury Via S-nitrosothiol Formation And Identification Of The Myocardial S-nitrosothiol Proteome
US 61/440,638 Abandoned
NICHD E-069-2000-2-US-13 Method Of Making And Using 7alpha, 11Beta-Dimethyl-17Beta-Hydroxyestr-4-En-3-One 17-Undecanoate US CON 13/022,391 10351587 Abandoned PDF
NCI E-106-2003-0-US-12 Griffithsin, Glycosylation-Resistant Griffithsin, And Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production And Methods Of Use US DIV 13/022,289 8394764 Issued PDF
NHGRI E-090-2010-0-NZ-04 METHODS OF DIAGNOSIS AND PROGNOSIS OF SKIN CANCER NZ National Stage 590993 Abandoned
NIA E-101-2010-0-PCT-02 Regulatory B Cells (tBregs) And Their Use PCT PCT PCT/US2011/023789 Expired
NCATS E-162-2008-0-US-07 Oxadiazole 2-oxides As AntiSchistosomal Agents US National Stage 13/057,667 Abandoned
NIDA E-030-2011-0-US-01 TRPA1 Gene Haplotype Associated With Menthol Preference In Two Samples Of European American Smokers US 61/439,419 Abandoned
NIAID E-088-2011-0-US-01 HIV Neutralizing Antibodies Having Mutations In Constant Domain(FC) US 61/439,678 Abandoned
NHLBI E-250-2010-0-US-01 Lightguides To Simplify Total Emission Detection For Multiphoton Microscopy US 61/439,616 Abandoned
NCI E-153-2008-0-US-06 Radioprotectants Targeting Thrombospondin-1 And CD47 US National Stage 13/057,447 8951527 Issued PDF